AndroGel Seasonal Use Considerations: A Clinical Guide

What Is AndroGel and Who Uses It?

AndroGel is a hydroalcoholic testosterone gel approved by the FDA for adult males with hypogonadism, a condition defined by serum total testosterone below 300 ng/dL on two morning measurements paired with clinical symptoms. The Endocrine Society's 2018 Clinical Practice Guideline defines hypogonadism as "a clinical syndrome that results from failure of the testes to produce physiological concentrations of testosterone." Roughly 2-4% of men under 40 and up to 20% of men over 60 carry this diagnosis. [1]

Two Formulations, One Drug

AndroGel 1% delivers 50 mg testosterone per 5 g packet or pump actuation. AndroGel 1.62% delivers 20.25 mg per pump actuation, allowing finer dose titration from 20.25 mg to 81 mg daily. The FDA product labeling for AndroGel 1.62% specifies a starting dose of 40.5 mg (2 actuations) applied to the upper arms and shoulders. [2]

The T-Trials Foundation

The landmark T-Trials (Testosterone Trials), a coordinated set of seven placebo-controlled trials in 788 men aged 65 or older with unequivocally low testosterone, confirmed that daily topical testosterone normalized serum levels and produced statistically significant improvements in sexual function, walking distance, bone mineral density, and anemia. The primary T-Trials publication in NEJM (N=788, Snyder et al., 2016) reported a mean serum testosterone increase from 234 ng/dL at baseline to 332-408 ng/dL in the testosterone arm. [3] That normalization depended on consistent, correct application, which seasonal factors can disrupt in ways the trial's controlled protocol minimized.

How Skin Physiology Changes With the Seasons

Testosterone gel works by passive diffusion through the stratum corneum into dermal capillaries. Anything that alters skin hydration, temperature, or surface sweating changes that diffusion gradient.

Summer: Heat, Sweat, and Reduced Adhesion

Skin temperature rises in summer. Elevated skin temperature increases cutaneous blood flow, which can in theory speed initial absorption, but the same heat drives eccrine sweat production. Sweat physically washes the gel from the skin surface before the 30-60 minute window in which the hydroalcoholic carrier evaporates and the testosterone depot forms. A pharmacokinetic study in the Journal of Clinical Endocrinology and Metabolism demonstrated that showering 1 hour after application reduced absorbed testosterone by approximately 13%, while showering 2 hours post-application had no significant effect on Cmax or AUC. [4] Spontaneous sweating equivalent to a brief shower can produce a similar wash-off effect.

Patients in hot climates or those with physically demanding outdoor jobs show serum testosterone values that may run 10-30% lower in summer months compared to winter draws, even on the same nominal dose. This drift is often misread as worsening hypogonadism or non-adherence.

Winter: Dry Skin, Clothing, and Vitamin D

Cold weather brings drier skin. The stratum corneum in dry skin has increased transepidermal water loss and a disrupted lipid bilayer, and research published in the British Journal of Dermatology found that barrier-disrupted skin shows altered permeation kinetics for lipophilic compounds. [5] For some patients, winter skin may actually absorb testosterone gel faster or more completely. For others, thick moisturizing creams applied to manage dry skin form an occlusive layer over the application site and reduce absorption.

Clothing also matters in winter. Men who apply gel to their upper arms and then immediately pull on a tight long-sleeved shirt transfer gel to the fabric. FDA guidance on AndroGel 1% instructs patients to let the gel dry completely (3-5 minutes) before dressing. [6] In warm-weather months, a short-sleeved shirt or no shirt is more common, reducing this interaction.

The Vitamin D Intersection

Vitamin D insufficiency peaks in winter at northern latitudes. A 2012 cross-sectional study in Clinical Endocrinology (N=2,299) found that men with 25-OH-D <20 ng/mL had significantly lower total and free testosterone compared to men with sufficient vitamin D, independent of age and BMI. [7] This seasonal vitamin D drop compounds the clinical picture. A man on a fixed AndroGel dose may experience worsened fatigue, low libido, or mood changes in winter that reflect vitamin D insufficiency as much as testosterone gel performance, making seasonal 25-OH-D screening a reasonable adjunct in the monitoring plan.

Pharmacokinetics: What the Label Says and What Practice Adds

Absorption Window and Peak Serum Levels

After a single application of AndroGel 1.62%, serum testosterone reaches Cmax at approximately 8-10 hours post-application in pharmacokinetic studies cited in the FDA prescribing information for AndroGel 1.62%. [2] Steady-state is reached within 24-48 hours of daily use. Clinically meaningful serum sampling should occur 2-8 hours post-application at steady-state, and the Endocrine Society 2018 guideline explicitly recommends checking levels 2-8 hours after application to capture the peak-to-trough range accurately. [1]

Inter-Individual Variability

Bioavailability from AndroGel 1% averages approximately 10% of the applied dose, but ranges from 5% to 17% across individuals in label pharmacokinetic data. [2] Skin thickness, hydration state, site vascularity, and body hair density all contribute to this spread. Seasonal variation in these parameters adds another layer of variability on top of the already wide inter-individual range.

Dihydrotestosterone (DHT) Elevation

Topical testosterone produces disproportionately high DHT levels compared to injected testosterone, because skin 5-alpha-reductase converts a portion of the applied testosterone locally. A pharmacokinetic comparison published in JCEM confirmed DHT-to-testosterone ratios roughly twice as high with transdermal vs. Intramuscular T. [8] Seasonal changes in skin 5-alpha-reductase activity are not well characterized, but clinicians monitoring patients who develop scalp hair thinning or prostate symptoms in summer (when absorption dynamics shift) should consider DHT as a variable.

Practical Seasonal Dosing Guidance

The table below summarizes a seasonal management framework developed by the HealthRX clinical team for patients on stable long-term AndroGel therapy. This is not a substitute for individualized clinical judgment.

| Season | Key Risk | Clinical Action | |--------|----------|-----------------| | Summer | Sweat wash-off, reduced Cmax | Apply at bedtime or early morning before heat exposure; check serum T at 8-week summer mark | | Winter | Vitamin D drop, clothing transfer, dry-skin barrier changes | Check 25-OH-D; confirm dry-before-dress technique; reassess if fatigue worsens | | Spring / Fall | Transition volatility | Recheck serum T within 6-8 weeks of season change if dose was adjusted |

Application Timing Adjustments in Hot Weather

The FDA-approved labeling for AndroGel 1% states that patients should avoid swimming or washing the application site for at least 2 hours after application. [6] In summer, this instruction deserves active reinforcement. A practical strategy is shifting application to bedtime in high-heat months. Nighttime skin temperature is lower, eccrine sweating is minimal, and the 2-hour occlusion period passes during sleep.

A 2009 study in Therapeutic Drug Monitoring found no clinically significant difference in 24-hour testosterone AUC between morning and evening application of a testosterone gel when steady-state measurements were used. [9] Switching to bedtime dosing in summer is therefore pharmacokinetically supported without requiring a dose change.

Dose Titration Thresholds

The Endocrine Society guideline recommends targeting a serum total testosterone in the mid-normal range, approximately 400-700 ng/dL, for most men on TRT. [1] If a summer draw comes back below 300 ng/dL despite reported adherence, a trial of the application-timing shift (morning to bedtime) is reasonable before escalating dose. If a winter draw exceeds 700 ng/dL, consider whether the same timing-shift is now overcorrecting.

The TRAVERSE trial (N=5,204), published in NEJM in 2023, reported that testosterone replacement in middle-aged and older men with hypogonadism and high cardiovascular risk did not significantly increase major adverse cardiac events over a mean follow-up of 33 months, with a hazard ratio of 1.07 (95% CI 0.94-1.21). [10] This safety context matters when clinicians consider liberal dose escalation in response to summer-driven low readings. Dose escalation carries real risks and should be a last resort after behavioral and timing strategies are tried.

Skin Preparation in Winter

Patients applying AndroGel to skin that is heavily moisturized should apply the moisturizer at least 1 hour before the testosterone gel, or use a different body area. A permeation study in the International Journal of Pharmaceutics demonstrated that co-application of petrolatum-based emollients reduced transdermal flux of model lipophilic drugs by 40-60% depending on emollient concentration. [11] Clinicians should ask about moisturizer use at every winter visit.

Transfer Risk Across Seasons

Secondary transfer of testosterone gel to female partners or children is a year-round safety concern, but it changes shape with the seasons.

Summer Transfer Scenarios

In summer, patients are more likely to be bare-armed and in close physical contact outdoors. The FDA black-box warning on AndroGel explicitly warns of virilization in women and children from skin contact. [2] A published case series in Pediatrics (N=9) documented premature virilization in boys whose fathers used testosterone gel without covering the application site. [12, via reference [13] below]

The 2-hour window before skin contact is the minimum safe interval per labeling, but covering the site with clothing or washing with soap and water before contact eliminates residual transfer risk entirely. In summer, tank tops or sleeveless shirts leave shoulders and upper arms exposed. Patients should be counseled to wear a covering shirt or wash the site before any skin-to-skin contact, regardless of season.

Winter Transfer Scenarios

Winter clothing typically covers application sites, reducing accidental transfer. This is one seasonal factor that works in patients' favor. The clothing barrier effectively substitutes for the "covered with clothing" instruction in the label.

Monitoring Schedule: Seasonal Checkpoints

Standard monitoring for men on testosterone gel includes serum total testosterone, hematocrit, PSA, and symptom assessment. The Endocrine Society 2018 guideline recommends checking testosterone 3-6 months after initiating therapy, then annually once stable. [1] Seasonal variation adds a practical argument for two annual checks: one in late summer (August-September) and one in late winter (February-March).

Hematocrit Monitoring

Testosterone therapy raises red cell mass. A meta-analysis in JAMA Internal Medicine (N=3,016 men across 52 trials) found a relative risk of polycythemia of 3.67 (95% CI 1.82-7.40) with testosterone therapy vs. Placebo. [14] Hematocrit should be checked at each seasonal monitoring visit. Dehydration in summer can falsely raise hematocrit readings, so same-day hydration status should be noted.

PSA Monitoring

The Endocrine Society recommends checking PSA at 3-12 months after initiation and then per standard prostate cancer screening guidelines. [1] PSA does not show strong seasonal variation, but it should be drawn at the same time-post-application (2-8 hours) as testosterone to maintain consistency in the clinical record.

Adding 25-OH-Vitamin D in Winter

A prospective study in Hormone and Metabolic Research (N=165 men) found that vitamin D supplementation in deficient men raised total testosterone by a mean of 69.8 ng/dL (P<0.001) compared to placebo over 12 months. [15] For men on AndroGel whose winter testosterone draws fall below target despite adherence, checking and correcting vitamin D deficiency (target 25-OH-D 40-60 ng/mL) may close part of the gap without a dose escalation.

Special Populations and Seasonal Considerations

Athletes and Outdoor Workers

Men with high sweat output due to occupational or recreational sun exposure represent the highest-risk group for summer absorption failure. An agricultural worker applying AndroGel at 6 a.m. And beginning physically demanding outdoor work at 7 a.m. Will sweat heavily over the application site within 60 minutes. Research on occupational heat stress published in the American Journal of Industrial Medicine documented sweat rates of 0.5-2.5 L/hour in outdoor workers in humid climates. [16] For this population, bedtime application is not just convenient but probably necessary for therapeutic levels.

Men With Obesity

Adipose tissue serves as a testosterone reservoir and metabolizes androgens via peripheral aromatization. A study in JCEM (N=1,849) confirmed that BMI is inversely associated with serum testosterone, with each 4-5 kg/m2 BMI increment associated with roughly 10 ng/dL lower total testosterone. [17] Obese men tend to sweat more in summer and have larger skin surface areas with potentially thicker subcutaneous fat, both of which may reduce gel-to-capillary diffusion efficiency. Clinicians should apply tighter seasonal monitoring intervals (every 8 weeks in the first summer on therapy) for men with BMI >35.

Older Men

The T-Trials population (mean age 72) had thinner skin than younger cohorts. A study in the British Journal of Dermatology on age-related skin changes found dermis thickness declines by approximately 6% per decade after age 50. [18] Thinner skin may mean faster initial uptake but also greater variability. Older men living in assisted-care settings are more likely to have consistent indoor temperatures year-round, which may actually reduce seasonal fluctuation for this subgroup.

Patient Education: Seasonal Checklist

Key instructions that should be reviewed with patients at the start of summer and winter:

Summer checklist:

• Apply at bedtime or at least 2 hours before anticipated heavy sweating
• Do not exercise or shower for 2 hours post-application
• Wear a covering shirt before skin contact with a partner or child
• Notify the prescriber if fatigue or libido worsens in July or August so a serum T check can be scheduled

Winter checklist:

• Apply moisturizer at least 1 hour before gel, or use a different site
• Let gel dry fully (3-5 minutes) before putting on a long-sleeved shirt
• Ask about 25-OH-D testing at the fall or winter visit
• Report new fatigue or mood symptoms; vitamin D, not dose failure, may be the cause

Summary of Key Evidence

The evidence base for seasonal AndroGel management draws on:

• The T-Trials (NEJM, 2016, N=788) establishing that topical testosterone can normalize serum levels in older men [3]
• FDA pharmacokinetic data for AndroGel 1% and 1.62% confirming a 2-hour critical absorption window [2, 6]
• The TRAVERSE trial (NEJM, 2023, N=5,204) establishing the cardiovascular safety context for dose decisions [10]
• The Endocrine Society 2018 guideline providing the monitoring and titration framework [1]
• Mechanistic studies on sweat, skin barrier, and vitamin D intersections [4, 5, 7, 15]

No head-to-head randomized trial has directly compared summer vs. Winter testosterone gel outcomes. This gap in the literature is the primary reason clinicians must rely on pharmacokinetic principles, mechanistic data, and careful seasonal monitoring rather than a single evidence-based protocol.

Men on AndroGel should have serum total testosterone checked in the 2-8 hour post-application window at a scheduled late-summer draw (August-September) and a late-winter draw (February-March) each year, with 25-OH-D added to the winter panel.